SCHEMBL4568615

SCHEMBL4568615

Cc1ccccc1Oc1nc(Nc2ccc(C#N)cc2)nc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 2/20 0.50
ABCG2 Q9UNQ0 5/20 0.47
ABCB1 P08183 2/20 0.47
ABCC3 O15438 1/20 0.47
ESR1 P03372 1/20 0.47
CYP1A2 P05177 1/20 0.47
PGR P06401 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADRA2A P08913 1/20 0.47
CYP2D6 P10635 1/20 0.47
CHRM1 P11229 1/20 0.47
CYP2C9 P11712 1/20 0.47
DRD1 P21728 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
ADORA1 P30542 1/20 0.47
CYP2C19 P33261 1/20 0.47
ABCC1 P33527 1/20 0.47
OPRM1 P35372 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568599 0.88 MERTK (0.50) MERTKABCG2ABCB1ABCC3ESR1
SCHEMBL4568602 0.85 MERTK (0.54) MERTKABCG2ABCB1KCNH2NPC1
SCHEMBL4568604 0.85 NPY5R (0.52) MERTKABCG2ABCB1ABCC3ESR1
SCHEMBL4568601 0.83 MAPT (0.59) MERTKCYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4568611 0.82 MAPT (0.50) MERTKABCG2ABCB1ABCC3ESR1
SCHEMBL4568605 0.81 ABCG2 (0.56) MERTKABCG2ABCB1ABCC3ESR1
SCHEMBL4568600 0.81 ABCG2 (0.51) MERTKABCG2ABCB1ABCC3ESR1
SCHEMBL7420353 0.80 SMN1; SMN2 (0.64) MERTKABCG2ABCB1NPC1RAB9A
SCHEMBL8898863 0.75 NPY5R (0.74) MERTKABCG2ABCB1CYP1A2KMT2A
Hydrochloric Acid SCHEMBL8890523 0.74 NPY5R (0.72) MERTKABCG2CYP1A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809343-B2 Pyrimidine derivative, preparation method and use thereof FUDAN UNIVERSITY (CN) 2014-08-19 US disclosed
US-8809343-B2 Pyrimidine derivative, preparation method and use thereof FUDAN UNIVERSITY (CN) 2014-08-19 US disclosed
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF FUDAN UNIVERSITY (CN) 2012-05-17 US disclosed
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF FUDAN UNIVERSITY (CN) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF DPYD, TYMP, TYMS MERTK 3234/4885ABCG2 136/4885ABCB1 634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.